Literature DB >> 15452314

Mutant ubiquitin UBB+1 is accumulated in sporadic inclusion-body myositis muscle fibers.

P Fratta1, W K Engel, F W Van Leeuwen, E M Hol, G Vattemi, V Askanas.   

Abstract

Mutant ubiquitin (UBB+1), a product of "molecular misreading," is toxic to cells because its ubiquitinated form inhibits the proteasome, contributing to accumulation of misfolded proteins and their ensuing toxicity. The authors demonstrate in 10 sporadic inclusion body myositis (s-IBM) muscle biopsies that UBB+1 is accumulated in aggregates containing amyloid-beta and phosphorylated-tau. In s-IBM, UBB+1 may be pathogenic by inhibiting proteasome, thereby promoting accumulation of cytotoxic misfolded amyloid-beta and phosphorylated-tau.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15452314     DOI: 10.1212/01.wnl.0000138574.56908.5d

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  14 in total

1.  Foxo/atrogin induction in human and experimental myositis.

Authors:  Han-Kyu Lee; Edward Rocnik; Qinghao Fu; Bumsup Kwon; Ling Zeng; Kenneth Walsh; Henry Querfurth
Journal:  Neurobiol Dis       Date:  2012-05       Impact factor: 5.996

2.  Proteasome inhibition and aggresome formation in sporadic inclusion-body myositis and in amyloid-beta precursor protein-overexpressing cultured human muscle fibers.

Authors:  Pietro Fratta; W King Engel; Janis McFerrin; Kelvin J A Davies; Sharon W Lin; Valerie Askanas
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

Review 3.  Cutting edge issues in polymyositis.

Authors:  Anna Ghirardello; Sandra Zampieri; Elena Tarricone; Luca Iaccarino; Luisa Gorza; Andrea Doria
Journal:  Clin Rev Allergy Immunol       Date:  2011-10       Impact factor: 8.667

4.  Characterizing polyubiquitinated forms of the neurodegenerative ubiquitin mutant UBB+1.

Authors:  Michal Chojnacki; Daoning Zhang; Monika Talarowska; Piotr Gałecki; Janusz Szemraj; David Fushman; Mark A Nakasone
Journal:  FEBS Lett       Date:  2016-11-22       Impact factor: 4.124

Review 5.  Inclusion-body myositis: muscle-fiber molecular pathology and possible pathogenic significance of its similarity to Alzheimer's and Parkinson's disease brains.

Authors:  Valerie Askanas; W King Engel
Journal:  Acta Neuropathol       Date:  2008-10-31       Impact factor: 17.088

6.  Ubiquitin over-expression phenotypes and ubiquitin gene molecular misreading during aging in Drosophila melanogaster.

Authors:  Nicholas Hoe; Chung M Huang; Gary Landis; Marian Verhage; Daniel Ford; Junsheng Yang; Fred W van Leeuwen; John Tower
Journal:  Aging (Albany NY)       Date:  2011-03       Impact factor: 5.682

7.  How citation distortions create unfounded authority: analysis of a citation network.

Authors:  Steven A Greenberg
Journal:  BMJ       Date:  2009-07-20

8.  Extended ubiquitin species are protein-based DUB inhibitors.

Authors:  Daria Krutauz; Noa Reis; Mark A Nakasone; Peter Siman; Daoning Zhang; Donald S Kirkpatrick; Steven P Gygi; Ashraf Brik; David Fushman; Michael H Glickman
Journal:  Nat Chem Biol       Date:  2014-07-06       Impact factor: 15.040

9.  Mutant ubiquitin attenuates interleukin-1β- and tumor necrosis factor-α-induced pro-inflammatory signaling in human astrocytic cells.

Authors:  Kyungsun Choi; Junseong Park; Jungsul Lee; Eun Chun Han; Chulhee Choi
Journal:  PLoS One       Date:  2013-07-03       Impact factor: 3.240

Review 10.  Ongoing developments in sporadic inclusion body myositis.

Authors:  Pedro M Machado; Mhoriam Ahmed; Stefen Brady; Qiang Gang; Estelle Healy; Jasper M Morrow; Amanda C Wallace; Liz Dewar; Gita Ramdharry; Matthew Parton; Janice L Holton; Henry Houlden; Linda Greensmith; Michael G Hanna
Journal:  Curr Rheumatol Rep       Date:  2014-12       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.